Calitech Co Ltd

Calitech maintains a strong liquidity position with $188.64 million in cash and equivalents, representing 15.2% of total assets, and a current ratio of 1.73, well above the industry median of 1.2. The company's debt-to-equity ratio is 0.0, indicating no long-term debt obligations, and its free cash flow of $35.28 million supports operational flexibility. Profitability metrics show mixed performance. Return on equity (ROE) of 3.33% and return on assets (ROA) of 2.6% lag behind the industry median ROE of 8.5% and ROA of 5.2%. Gross margin of 33.8% is in line with the sector average, but operating margin of 21.2% is below the median of 24.7%, suggesting inefficiencies in cost control or pricing power. The company operates as a single business segment, with all revenue derived from semiconductor testing equipment. Geographic exposure is not disclosed in the latest filings, but the industry is heavily concentrated in East Asia, with 65% of global revenue generated in the region. Calitech's lack of geographic diversification introduces concentration risk. Revenue growth has been modest, with a 4.2% year-over-year increase to $166.94 million. Outlook for the current fiscal year is for 3.8% growth, with a 2.1% increase expected in the following year. This trajectory is below the industry's 7.5% average growth rate, reflecting challenges in scaling production or capturing market share. Risk factors include low liquidity and dilution risk, with no immediate filing-based flags detected. The company has no long-term debt and a low debt-to-equity ratio, but its price-to-earnings ratio of 117.2 is significantly higher than the industry median of 28.5, indicating potential overvaluation. No dilutive events were identified in recent filings. Recent events include a 10-K filing disclosing no material changes in business operations or capital structure. The company has not issued new shares in the past 12 months, and no shelf registration or ATM programs are currently active. Earnings per share (EPS) of 2.61 TWD in the latest quarter align with analyst estimates.